FIELD: medicine, pharmacy. SUBSTANCE: invention relates to pharmacology and can be used in treatment of cough syndrome. Invention relates to a medicinal agent comprising mixture of two components. One component presents the activated form of supersmall doses of monoclonal, polyclonal, immune or natural antibodies raised to morphine. Another component presents the activated form of supersmall doses of monoclonal, polyclonal, immune or natural antibodies raised to bradykinin obtaining by multiple successive dilution and external effect. This agent is prepared by method of homeopathic technology mainly. Invention relates also to method of treatment of cough syndrome including administration of indicated medicinal agent. Invention provides the development of effective medicinal agent for treatment of cough syndrome effecting on central and peripheral mechanisms of induction of cough reflex and no inducing by-side symptoms. Invention can be used for treatment of cough syndrome. EFFECT: enhanced effectiveness of agent and treatment. 3 cl, 6 ex
Authors
Dates
2003-02-27—Published
2001-12-07—Filed